FDA inspection
Shilpa Medicare Limited: FDA inspection ending Feb 13, 2019
FDA inspection 1079090 · Voluntary Action Indicated (VAI) · Bengaluru
Key facts
| Inspection ID | 1079090 |
|---|---|
| Firm | Shilpa Medicare Limited |
| FEI number | 3010619401 |
| Address | R&D Unit, Survey 207, Modavalasa Village, Denkada Mandalam |
| City | Bengaluru |
| Country | India |
| Fiscal year | 2019 |
| Inspection end date | Feb 13, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data